Emerg Infect DisEIDEmerging Infectious Diseases1080-60401080-6059Centers for Disease Control and Prevention20507778308624110-022810.3201/eid1606.100228Letters to the EditorIncreasing Incidence of Nontuberculous Mycobacteria, Taiwan, 2000–2008Hernández-GarduñoEduardoElwoodR. KevinBritish Columbia Centre for Disease Control, Vancouver, British Columbia, CanadaAddress for correspondence: Eduardo Hernández-Garduño, Department of Tuberculosis Control, British Columbia Centre for Disease Control, 1063-655 W 12th Ave, Vancouver, British Columbia V5Z 4R4, Canada; email: eduardo.hernandez@bccdc.ca6201016610471048LaiCC , TanCK , ChouCH , HsuHL , LiaoCH , HuangYT , Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008.Emerg Infect Dis. 2010;16:294–6.20113563Keywords: Nontuberculous mycobacteriabacteriadiseasecolonizationTaiwanletter

To the Editor: Lai et al. (1) reported an increase in the number of nontuberculous mycobacteria (NTM) isolates and patients with pulmonary NTM diseases after implementation of the BACTEC system (Becton Dickinson, Sparks, MD, USA) late in 2001. These authors also reported that the increase was mainly in persons infected with Mycobacterium avium complex (MAC) and M. abscessus. They stated that diseases caused by NTM were defined according to current diagnosis criteria published in 2007 (2). This finding suggests that Lai et al. were able to review the clinical and radiologic information for all patients.

We wonder whether they were also able to identify and exclude people with NTM colonization, i.e., persons with positive cultures for NTM who did not meet the American Thoracic Society disease criteria. It would have been interesting to know the trend in colonized persons. In a previous study from British Columbia (3), we found an increase in the number of NTM isolates mostly in persons with MAC colonization. This finding coincided with implementation of a new laboratory technique in 2000, which suggested that the new technology is more sensitive in detecting MAC. In contrast with the findings of Lai et al., our study from British Columbia showed that the incidence in patients treated for NTM pulmonary disease (the group used as a surrogate of NTM disease) has been decreasing over time, which is reassuring.

Suggested citation for this article: Hernández-Garduño E, Elwood RK. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008 [letter]. Emerg Infect Dis [serial on the Internet]. 2010 Jun [date cited]. http://www.cdc.gov/EID/content/16/6/1047.htm

ReferencesLai CC, Tan CK, Chou CH, Hsu HL, Liao CH, Huang YT, Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis. 2010;16:294–620113563Griffith DE, Aksamit T, Brow-Elliott BA, Catanzaro A, Daley C, Gordin F, An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416 .10.1164/rccm.200604-57117277290Hernández-Garduño E, Rodrigues M, Elwood RK The incidence of pulmonary non-tuberculous mycobacteria in British Columbia, Canada. Int J Tuberc Lung Dis. 2009;13:1086–9319723396Emerg Infect DisEIDEmerging Infectious Diseases1080-60401080-6059Centers for Disease Control and Prevention10-032910.3201/eid1606.100329Letters to the EditorIncreasing Incidence of Nontuberculous Mycobacteria, Taiwan, 2000–2008LaiChih-ChengTanChe-KimChouChien-HongHsuHsaio-LengLiaoChun-HsingHuangYu-TsungYangPan-ChyrLuhKwen-TayHsuehPo-RenCardinal-Tien Hospital, Taipei, Taiwan (C.-C. Lai); Chi-Mei Medical Center, Tainan, Taiwan (C.-K. Tan)National Taiwan University College of Medicine, Taipei (C.-H. Chou, H.-L. Hsu, Y.-T. Huang, P.-C. Yang, K.-T. Luh, P.-R. Hsueh)Far Eastern Memorial Hospital, Taipei (C.-H. Liao)Address for correspondence: Po-Ren Hsueh, Departments of Laboratory Medicine and Internal Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Rd, Taipei 100, Taiwan; email: hsporen@ntu.edu.tw6201016610471048

In Response: We thank Hernández-Garduño and Elwood for drawing attention to the issue of nontuberculous mycobacteria (NTM) colonization (1), which was not described in our study (2). Among 4,786 patients with NTM isolates treated at our hospital during 2000–2008, colonization was found in 76.9% (3,681), and only 23.1% (1,105) had NTM diseases according to the criteria of the American Thoracic Society and Infectious Diseases Society of America (3).

Annual proportions of NTM isolates causing colonizations ranged from 29.2% in 2001 to 19.8% in 2007. During the study period, annual incidences of NTM colonization and disease increased from 6.6/100,000 inpatients and 2.7/100,000 outpatients in 2000 to 34.5/100,000 inpatients and 10.2/100,000 outpatients in 2008. Mycobacterium avium complex (MAC) was the most prevalent species, colonizing 1,282 (34.8%) of 3,681 patients. Annual proportions of MAC isolates causing colonization ranged from 20.0% in 2000 to 12.6% in 2006. Annual incidence of MAC colonization increased from 1.9/100,000 inpatients in 2000 to 12.3/100,000 inpatients in 2008; incidence of MAC disease also increased from 0.5/100,000 inpatients in 2000 to 2.1/100,000 inpatients in 2008. M. abscessus, the second most common species in our study (2), caused colonization and disease in 669 and 155 patients, respectively. Annual incidence of M. abscessus colonization and infection also increased from 1.49/100,000 inpatients and 0.3/100,000 outpatients in 2000 to 7.0/100,000 inpatients and 1.9/100,000 outpatients in 2008.

Our study and a previous study in British Columbia (4) suggest that improvement in diagnostic methods would detect increased incidence of NTM, especially of MAC; most isolates identified in these studies were associated with colonization. We also demonstrated a gradual increase in the incidence of all NTM, MAC, and M. abscessus over time in Taiwan, which may be attributable to increasing vigilance and awareness of these bacteria as human pathogens and the increased population of immunocompromised patients. Thus, clinicians should consider diagnosing NTM diseases with sensitive and advanced laboratory methods because of the increasing population of patients at risk.

ReferencesHernández-Garduño E, Elwood RK Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis. 2010;16:104720507778Lai C-C, Tan C-K, Chou C-H, Hsu H-L, Liao C-H, Huang Y-T, Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis. 2010;16:294–620113563Griffith DE, Aksamit T, Brow-Elliott BA, Catanzaro A, Daley C, Gordin F, An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416 10.1164/rccm.200604-571ST17277290Hernández-Garduño E, Rodrigues M, Elwood RK The incidence of pulmonary nontuberculous mycobacteria in British Columbia, Canada. Int J Tuberc Lung Dis. 2009;13:1086–9319723396